Targeting Strategies for Osteoarthritis: Biomaterials, Joint-Specific Drug Delivery, and Translational Progress

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Biotechnology

Background:

• Osteoarthritis (OA) is a degenerative joint disease with limited therapeutic options due to cartilage's dense matrix and rapid drug clearance.
• Complex joint structures like the intervertebral disc, meniscus, and TMJ disc present unique anatomical and biomechanical challenges for treatment.
• OA's microenvironment, characterized by acidic pH and elevated reactive oxygen species (ROS), offers potential for targeted therapies.

Purpose of the Study:

• To review bioreactor technologies for simulating joint environments and screening OA therapies.
• To examine microscopic changes in joint structure as therapeutic barriers and opportunities.
• To highlight smart biomaterials and delivery systems for targeted OA treatment.

Main Methods:

• Review of bioreactor technologies for OA research.
• Analysis of microscopic changes in joint tissues.
• Examination of smart biomaterials responsive to pH and ROS.
• Summary of tissue-specific targeting and delivery systems for joint structures.

Main Results:

• Bioreactors provide platforms for studying OA pathogenesis and therapy screening.
• Smart biomaterials leveraging OA-specific cues (pH, ROS) enable site-specific drug delivery.
• Targeting strategies for superficial and deep cartilage layers are being developed.
• Delivery systems are being tailored for complex joint structures, with translational progress noted.

Conclusions:

• Exploiting OA-specific microenvironmental cues is a promising strategy for targeted and responsive treatment.
• Smart biomaterials and advanced delivery systems are crucial for overcoming therapeutic challenges in OA.
• Emerging approaches show potential for bridging laboratory research and clinical application in osteoarthritis management.